Chief Scientific Officer CRF Newton, Massachusetts, United States
Disclosure information not submitted.
Disclosure(s):
Jeffrey J. Popma, MD: Medtronic: CMO ended Nov 2024 (Terminated, November 1, 2024), Stock-publicly held company (excluding mutual/index funds) (Terminated, November 1, 2024)
